Estée Lauder Companies vs Constellation Brands
Global luxury beauty company selling makeup and skincare vs Major North American producer of premium alcoholic beverages. Which is the better buy for your portfolio in August 2026? Plain-English answer below.
Estee Lauder built its empire on prestige beauty brands sold through department stores and travel retail, while Constellation Brands distributes premium beer, wine, and spirits through U.S. wholesale channels, putting two consumer companies with pricing power in front of very different post-pandemic demand dynamics. Both rely on brand investment and channel relationships to sustain premium price points. Estee Lauder Companies vs Constellation Brands tracks revenue recovery, channel mix shifts, and which management team is more effectively navigating its sector's unique headwinds.
Estee Lauder built its empire on prestige beauty brands sold through department stores and travel retail, while Constellation Brands distributes premium beer, wine, and spirits through U.S. wholesale ...
Why It’s Moving
Estée Lauder is moving as investors brace for its August 19 earnings test and a read on recovery momentum.
- Earnings are the main catalyst: Estée Lauder is scheduled to report fiscal fourth-quarter and full-year results on August 19, and investors are positioning for clues on whether the company can sustain its recovery into the new fiscal year.
- Recent analyst commentary has leaned constructive, with consensus sentiment still tilted toward a Buy and some price-target revisions pointing to improved confidence in the brand’s earnings trajectory ahead of the report.
- The stock is also reacting to the broader luxury-beauty backdrop, where demand trends, China exposure, and margin recovery remain the key swing factors that could amplify moves if management’s outlook surprises either way.
STZ is moving as Berkshire’s exit and a tougher alcohol backdrop reshape investor sentiment.
- Berkshire Hathaway’s reported exit from STZ weighed on sentiment, with investors reacting to the loss of a prominent long-term backer rather than any new company-specific operating surprise.
- The stock has also been trading against a softer backdrop for alcohol names, as the sector faces volume pressure, uneven consumer demand, and cost headwinds that can cap near-term upside.
- Recent trading has been choppy: the shares briefly firmed on market strength, but the sharper reaction to Berkshire’s sale shows the market is still sensitive to changes in institutional ownership and analyst positioning.
Estée Lauder is moving as investors brace for its August 19 earnings test and a read on recovery momentum.
- Earnings are the main catalyst: Estée Lauder is scheduled to report fiscal fourth-quarter and full-year results on August 19, and investors are positioning for clues on whether the company can sustain its recovery into the new fiscal year.
- Recent analyst commentary has leaned constructive, with consensus sentiment still tilted toward a Buy and some price-target revisions pointing to improved confidence in the brand’s earnings trajectory ahead of the report.
- The stock is also reacting to the broader luxury-beauty backdrop, where demand trends, China exposure, and margin recovery remain the key swing factors that could amplify moves if management’s outlook surprises either way.
STZ is moving as Berkshire’s exit and a tougher alcohol backdrop reshape investor sentiment.
- Berkshire Hathaway’s reported exit from STZ weighed on sentiment, with investors reacting to the loss of a prominent long-term backer rather than any new company-specific operating surprise.
- The stock has also been trading against a softer backdrop for alcohol names, as the sector faces volume pressure, uneven consumer demand, and cost headwinds that can cap near-term upside.
- Recent trading has been choppy: the shares briefly firmed on market strength, but the sharper reaction to Berkshire’s sale shows the market is still sensitive to changes in institutional ownership and analyst positioning.
Investment Analysis
Pros
- Estée Lauder reported Q4 EPS above expectations, showing resilience in a challenging prestige beauty market.
- The company expanded gross margins by 230 basis points, reflecting improved cost management and operational efficiency.
- China sales are stabilising with signs of market share gains, offering potential for future revenue recovery.
Considerations
- Organic sales declined by 8% for the full fiscal year, indicating persistent demand headwinds in key markets.
- Operating margin contracted by 220 basis points, highlighting ongoing profitability pressures despite margin improvements.
- Stock price remains volatile, with recent declines despite earnings beats, reflecting investor concerns over growth prospects.
Pros
- Constellation Brands benefits from exclusive US rights to high-growth Mexican beer brands like Corona and Modelo.
- The company operates with best-of-breed margins and is well-positioned to capitalise on strong secular beverage trends.
- Shares trade at a notable discount to fair value estimates, suggesting potential upside for value-oriented investors.
Considerations
- Recent quarterly EPS declined by 16%, reflecting short-term profitability challenges in the beverage segment.
- The business faces evolving industry dynamics, including shifting consumer preferences and competitive pressures.
- Exposure to regulatory and macroeconomic risks in the alcohol sector could impact future growth and margins.
next-earnings-date-heading
The next earnings date for EL is expected on November 2, 2026, based on its current reporting pattern. That release would cover fiscal Q1 2027. If the company confirms its schedule earlier, the date could shift slightly.
next-earnings-date-heading
The next earnings date for STZ is expected to be October 5, 2026, based on the company’s historical reporting pattern. This release should cover first quarter fiscal 2027 results, for the quarter ended May 31, 2026. The date is an estimate and may shift slightly if the company formally confirms a different schedule.
next-earnings-date-heading
The next earnings date for EL is expected on November 2, 2026, based on its current reporting pattern. That release would cover fiscal Q1 2027. If the company confirms its schedule earlier, the date could shift slightly.
next-earnings-date-heading
The next earnings date for STZ is expected to be October 5, 2026, based on the company’s historical reporting pattern. This release should cover first quarter fiscal 2027 results, for the quarter ended May 31, 2026. The date is an estimate and may shift slightly if the company formally confirms a different schedule.
Buy EL or STZ in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
